Palazestrant Clinical Trials

2 actively recruiting trials across 2 locations

▼ -2 trials since August 2026

Also known as: OP-1250

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

Olema Pharmaceuticals, Inc.2

Indications

Metastatic Breast Cancer2
Breast Cancer2
Cancer2
Palazestrant1
Fulvestrant1

Hot Springs, Arkansas1 trial

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site

Phase 3

Sarasota, Florida1 trial

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Florida Cancer Specialists

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.